Debiopharm in-licenses heart failure compound

Sigma-Tau (Rome, Italy) granted Debiopharm (Lausanne, Switzerland) global development and commercialization rights to istaroxime, excluding Italy. Istaroxime is a luso-inotropic agent that modulates c...